“Research indicates that seasonal affective low mood may be informed by some people’s response to a decrease in daylight ...

The approval is supported by a combination of current clinical data and model-informed drug development techniques.

The FDA expanded the approval of once-monthly risperidone (Uzedy) to include adjunct treatment for bipolar I disorder, ...

Paris: The FDA has approved UZEDY, the first subcutaneous long-acting risperidone formulation utilizing SteadyTeq™ technology ...

Misuse of mental health terms is blurring the lines between everyday stress and clinical disorders, fostering self-diagnosis ...

A 43-year-old woman with bipolar disorder and advanced HIV infection was admitted to this hospital because of depressed mood, ...

Moment of Clarity has released a new resource, titled “Using TMS Therapy for BPD Recovery,” now available on their website.

Based on RNA editing and artificial intelligence, the myEDIT-B test reflects an emerging focus on precision psychiatry, providing a biological tool that complements clinical diagnosis.

One of Gov. Gavin Newsom's marquee mental health programs may broaden its reach despite persistent questions about the number ...

The scientific community is increasingly paying attention to the relationship between skin condition and mental health. A new ...

A registered dietitian nutritionist discusses creatine's safety and effectiveness for cognitive and physical benefits, ...